Literature DB >> 22477578

Adverse effect of low-dose amiodarone mimicking pulmonary malignancy.

Hsiao-Ching Cheng1, Jao-Hsien Wang, Ming-Long Wang, Ming-Tse Sung, Shoa-Lin Lin, Tahir Tak.   

Abstract

A 74-year-old woman presented with a one-week history of persistent cough. A chest x-ray and computed tomography images revealed features mimicking lung cancer, which included a large solitary consolidation and hilar lymphadenopathy. She had received low-dose amiodarone (200 mg/day) for treatment of atrial fibrillation for more than 2.5 years. The tumour-like abnormalities did not disappear until the discontinuation of amiodarone therapy. The finding of low-dose amiodarone causing tumour-like abnormalities on a chest x-ray is unique. Once amiodarone-induced tumour-like changes are diagnosed, therapeutic options are limited. In most cases, the tumour-like changes are reversible, if diagnosed early. An unusual case involving amiodarone-induced pulmonary abnormalities is reported, followed by a review of the relevant literature.

Entities:  

Year:  2010        PMID: 22477578      PMCID: PMC2949988          DOI: 10.1055/s-0031-1278364

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  10 in total

1.  Is amiodarone an underrecognized cause of acute respiratory failure in the ICU?

Authors:  H Ashrafian; P Davey
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

2.  Adverse effects of low dose amiodarone: a meta-analysis.

Authors:  V R Vorperian; T C Havighurst; S Miller; C T January
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

Review 3.  Clinical aspects of amiodarone pulmonary toxicity.

Authors:  J I Kennedy
Journal:  Clin Chest Med       Date:  1990-03       Impact factor: 2.878

4.  Pulmonary toxicity in patients receiving low-dose amiodarone.

Authors:  Michael C Ott; Andras Khoor; Jack P Leventhal; Timothy E Paterick; Charles D Burger
Journal:  Chest       Date:  2003-02       Impact factor: 9.410

5.  Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.

Authors:  S M Sobol; L Rakita
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

6.  Acute amiodarone-induced lung toxicity.

Authors:  L Donaldson; I S Grant; M R Naysmith; J S Thomas
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

7.  The role of free radicals in the pathogenesis of amiodarone toxicity.

Authors:  A Vereckei; A Blazovics; I Gyorgy; E Feher; M Toth; G Szenasi; A Zsinka; G Foldiak; J Feher
Journal:  J Cardiovasc Electrophysiol       Date:  1993-04

8.  Clinical features of amiodarone-induced pulmonary toxicity.

Authors:  R E Dusman; M S Stanton; W M Miles; L S Klein; D P Zipes; N S Fineberg; J J Heger
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

9.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

10.  Bronchiolitis obliterans organizing pneumonia.

Authors:  G R Epler; T V Colby; T C McLoud; C B Carrington; E A Gaensler
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

  10 in total
  2 in total

1.  ECMO for pulmonary rescue in an adult with amiodarone-induced toxicity.

Authors:  Filippo Benassi; Alberto Molardi; Elena Righi; Rosaria Santangelo; Marco Meli
Journal:  Heart Vessels       Date:  2014-03-07       Impact factor: 2.037

2.  Amiodarone Toxicity Presenting with Acute Onset of Systemic Inflammatory Response Syndrome and Multiorgan Failure Mimicking Sepsis.

Authors:  Irfanali R Kugasia; Mohsin Ijaz; Ahsan Khan; Yashwanth Jasti
Journal:  Am J Case Rep       Date:  2020-10-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.